Ndezure, E.; Ibrahim, I.; Abugri, J.; Ayariga, J. Drugs, Vaccines and Druggable Targets of Salmonella Typhi. Preprints2023, 2023110732. https://doi.org/10.20944/preprints202311.0732.v1
APA Style
Ndezure, E., Ibrahim, I., Abugri, J., & Ayariga, J. (2023). Drugs, Vaccines and Druggable Targets of Salmonella Typhi. Preprints. https://doi.org/10.20944/preprints202311.0732.v1
Chicago/Turabian Style
Ndezure, E., James Abugri and Joseph Ayariga. 2023 "Drugs, Vaccines and Druggable Targets of Salmonella Typhi" Preprints. https://doi.org/10.20944/preprints202311.0732.v1
Abstract
Despite recent public health and hygiene advancements, enteric fever, commonly referred to as typhoid fever, remains a common disease in developing nations. The common mode of infection is contaminated water or food. Additionally, person-to-person transmission through poor hygiene and sewage contamination of water supplies has been blamed for most outbreaks. The exact burden of typhoid has yet to be discovered because of the lack of surveillance systems in many developing nations. This makes it difficult to estimate the number of cases. Recent studies have shown that the actual number of cases of typhoid has been estimated to be around 21.6 million annually. The mortality studies suggest that the incidence of typhoid is highest in children under five years old. Typhoid fever and paratyphoid fever have been demonstrated to be life-threatening illnesses. Salmonella serotype Typhi (S. Typhi) is the causative organism of typhoid fever whereas Salmonella serotype Paratyphi is the causative organism for paratyphoid fever. The S. Typhi bacterium is known to be resistant to various drugs. There is a dire need to develop new drugs to treat and overcome the current drug-resistant S. Typhi. The identification of new targets marks the beginning of the process of developing new anti-S. Typhi drugs. The S. Typhic genome sequencing and recent cutting-edge molecular biology tools have led to the discovery of numerous new inhibitors and targets. The goal of this review is to identify the most critical targets in the S. Typhi that are targeted by drugs. It also highlights the various promising vaccines on the market or are still in preclinical studies. A detailed understanding of the targets could help researchers develop safer and more efficient antibacterial agents against S. Typhi.Additionally, the advancement of molecular techniques and the knowledge of the Salmonella pathogenesis pathways have opened better avenues to develop effective antibiotics and vaccines against this pathogen. This review also sought to identify and summarize critical structures of this pathogen that play significant roles in the maturation, development, and pathogenesis of S. Typhi. The endpoint of this work is to provide valuable information on potential therapeutic targets of S. Typhi for drug and vaccine developers.
Keywords
Salmonella Typhi; Typhoid Fever; Fimbriae; Vaccine; Antibacterial Agent; Drug Target
Subject
Biology and Life Sciences, Immunology and Microbiology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
